552 related articles for article (PubMed ID: 20848431)
1. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
4. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
Odeyinde SO; Kangesu L; Badran M
J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
8. Ethanol sclerotherapy of peripheral venous malformations.
Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
[TBL] [Abstract][Full Text] [Related]
9. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
10. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
[TBL] [Abstract][Full Text] [Related]
11. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
[TBL] [Abstract][Full Text] [Related]
12. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
[TBL] [Abstract][Full Text] [Related]
13. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate.
Zhao JH; Zhang WF; Zhao YF
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):463-6. PubMed ID: 15183410
[TBL] [Abstract][Full Text] [Related]
15. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
Chen WL; Huang ZQ; Zhang DM; Chai Q
Head Neck; 2010 Apr; 32(4):467-72. PubMed ID: 19672870
[TBL] [Abstract][Full Text] [Related]
18. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
